Physician profile
Marina Ostapenko
NPI 1699337303
$449.96
in general payments reported to CMS, 2019-2025
9 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $76.23 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $161.80 | 2022-2025 | Myrisk |
| Mayne Pharma Commercial LLC | $112.68 | 2023-2025 | |
| Celgene Corporation | $45.62 | 2022 | |
| Scynexis, INC. | $30.02 | 2022 | |
| Astellas Pharma US INC | $22.67 | 2025 | Veozah |
| Evofem Biosciences, INC. | $22.61 | 2022 | |
| Millicent US INC | $22.38 | 2025 | Intrarosa |
| Smith+Nephew, INC. | $17.91 | 2025 | Pico 14 |
| Exeltis, USA INC. | $14.27 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Ostapenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.